US Investigates GSK Following Chinese Bribery Claims
U.S. prosecutors have begun investigating British drug giant GlaxoSmithKline PLC for violations of foreign bribery laws after Chinese officials launched their own probe into allegations the company bribed doctors to win...To view the full article, register now.
Already a subscriber? Click here to view full article